Open access · CC-BY
via OpenAlex
The Peripheral Inflammatory Response to Alpha-Synuclein and Endotoxin in Parkinson's Disease
Alice J. White, Ruwani Wijeyekoon, Kirsten M. Scott, Nushan P Gunawardana, Shaista Hayat, Imtiaz H. Solim, Harvey T. McMahon, Roger A. Barker, Caroline H. Williams‐Gray
Frontiers in Neurology · 2018 · ▲ 59 citations
Abstract
The immune system is activated in Parkinson's Disease (PD), as evidenced by neuroinflammatory changes within the brain as well as elevated immune markers in peripheral blood. Furthermore, inflammatory cytokine levels in the blood are associated with disease severity and rate of progression. However, the factors driving this immune response in PD are not well established. We investigated cell-extrinsic factors in systemic immune activation by using α-synuclein monomers and fibrils, as well as bacterial toxins, to stimulate peripheral blood mononuclear cells (PBMCs) derived from 31 patients and age/gender-matched controls. α-synuclein monomers or fibrils resulted in a robust cytokine response (as measured by supernatant cytokine concentrations and mRNA expression in cultured cells) in both PD and control PBMCs, similar to that induced by bacterial LPS. We found no PD vs. control differences in cytokine production, nor in mRNA expression. Levels of endotoxin within the recombinant α-synuclein used in these experiments were very low (0.2-1.3EU/mL), but nonetheless we found that comparable levels were sufficient to potentially confound our cytokine concentration measurements for a number of cytokines. However, α-synuclein monomers increased production of IL-1β and IL-18 to levels significantly in excess of those induced by low-level endotoxin. In conclusion, this study: (i) highlights the importance of accounting for low-level endotoxin in antigen-PBMC stimulation experiments; (ii) indicates that cell-extrinsic factors may be a major contributor to immune activation in PD; and (iii) suggests that α-synuclein may play a role in inflammasome-related cytokine production in the periphery.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fneur.2018.00946
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
White, A.J., Wijeyekoon, R., Scott, K.M., Gunawardana, N.P., Hayat, S., Solim, I.H., McMahon, H.T., Barker, R.A., & Williams‐Gray, C.H. (2018). The Peripheral Inflammatory Response to Alpha-Synuclein and Endotoxin in Parkinson's Disease. <em>Frontiers in Neurology</em>. https://doi.org/10.3389/fneur.2018.00946
Vancouver
White AJ, Wijeyekoon R, Scott KM, Gunawardana NP, Hayat S, Solim IH, et al. The Peripheral Inflammatory Response to Alpha-Synuclein and Endotoxin in Parkinson's Disease. Frontiers in Neurology. 2018. doi:10.3389/fneur.2018.00946.
BibTeX
@article{alice2018ThePer,
title = {The Peripheral Inflammatory Response to Alpha-Synuclein and Endotoxin in Parkinson's Disease},
author = {Alice J. White and Ruwani Wijeyekoon and Kirsten M. Scott and Nushan P Gunawardana and Shaista Hayat and Imtiaz H. Solim and Harvey T. McMahon and Roger A. Barker and Caroline H. Williams‐Gray},
journal = {Frontiers in Neurology},
year = {2018},
doi = {10.3389/fneur.2018.00946},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging 2015
Open access · CC-BY
Increased epigenetic age and granulocyte counts in the blood of Parkinson's disease patients
PLoS ONE 2013
Open access · CC-BY
TOM40 Mediates Mitochondrial Dysfunction Induced by α-Synuclein Accumulation in Parkinson’s Disease
Movement Disorders 2018
Open access · CC-BY
Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cells
Acta Neuropathologica 2016
Open access · CC-BY
Toll-like receptor 2 is increased in neurons in Parkinson’s disease brain and may contribute to alpha-synuclein pathology
PLoS ONE 2010
Open access · CC-BY
Microglia Acquire Distinct Activation Profiles Depending on the Degree of α-Synuclein Neuropathology in a rAAV Based Model of Parkinson's Disease
Protein & Cell 2025
Open access · CC-BY